A lot has been stated about the Maintenance of Certification (MOC) implemented by the American Board of Internal Medicine (ABIM,) and many physicians, regardless of specialty, have been opposed to the MOC as it adds cost, burden, and takes away from patient care. This led Dr. Aaron Goodman from UCSD to start a petition to end the MOC, which gathered unwavering support with over 10,000 signatures in 2 weeks. In response, Dr. Richard Baron, the president and CEO of ABIM, has agreed to come on the show to address the concerns raised by physicians and to answer questions that have flooded all social media channels since the petition started.
What is the history of certification, recertification, and MOC? What is the “Grandfather” rule? What about data? COI? Cost? Burnout? Does the MOC really lead to better patient care? Why not stick to state-regulated CME courses? These issues are top-of-mind for a large number of physicians who are certified by the ABIM.
You will not want to miss this heated, yet respectful and civil, discussion.
In the podcast, there is a mention of COIs. The ABIM has provided links to their COI.
Dr. Baron’s specific COI are also listed: https://www.abim.org/about/leadership/#baron
The ABIM Board of Directors page lists all of their COIs as well: https://www.abim.org/about/boards-and-committees/governance/board-of-directors/
Here is the page for all the Specialty Boards: https://www.abim.org/about/boards-and-committees/
View the petition: https://www.change.org/p/eliminate-abims-moc-requirement
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he delves into pivotal studies such as CheckMate 914 Part B and KEYNOTE-564, exploring their implications
Dr. LaBelle elucidates the complexities of sickle cell disease, unraveling the devastating impact it has on individuals. The episode delves into various treatments and approaches to combat this formidable disease, including bone marrow transplant and the groundbreaking use of CRISPR-Cas9 technology. LaBelle shares insights into the recent research breakthroughs, citing the remarkable research report published
n this poignant episode, USA Today investigative journalist Emily Le Coz unravels the heart-wrenching narrative of Ashleigh Anderson, a CVS pharmacist whose tragic demise serves as a cautionary tale of overwhelming stress in the workplace. Emily shares her motivations behind delving into the pervasive issue of burnout in retail pharmacy and sheds light on the
